Skip to main content
Equibles

UBS Group AG

Position in TNXP — Tonix Pharmaceuticals Holding Corp.

CIK 1610520 ZURICH, V8
Back to TNXP Full portfolio

Position in TNXP

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,956,261
-$229,311 QoQ
Shares Held
231,682
+0.0% QoQ
Ownership
1.35%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 103 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TNXP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. TNXP ranks #183 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in TNXP

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,956,261 231,682
2026-03-31 $3,185,572 231,678
2025-12-31 $1,428,588 91,459
2025-09-30 $1,246,195 51,581
2025-06-30 $808,218 22,463
2025-03-31 $357,045 19,969
2024-12-31 $584,126 1,770,080
2024-09-30 $36,045 240,300
2024-06-30 $35 50
2023-03-31 $15,219 25,795
2022-12-31 $26,335 67,528
2022-09-30 $188 356
2022-06-30 $38,023 24,066
2022-03-31 $58,638 254,952
2021-12-31 $120,305 334,183
2021-09-30 $6 11
2021-06-30 $9,090 8,190
2021-03-31 $14 11
2020-12-31 $7 11
2020-09-30 $9 11
2020-06-30 $616 1,011
2020-03-31 $7 11